nanomedicine : nanotechnology, biology, and medicine

transfusion medicine reviews

[1] Antiplatelet effect of differentially charged PEGylated lipid-polymer nanoparticles.

[2] The Lipid Composition of Platelets and the Impact of Storage: An Overview.

[3] platelet rich plasma for traumatic non-union fractures: a novel but controversial bone regeneration strategy

[4] ectonucleoside triphosphate diphosphohydrolase-1/cd39 affects the response to adp of female rat platelets

[5] platelet gene therapy promotes targeted peripheral tolerance by clonal deletion and induction of antigen-specific regulatory t cells

[6] β2gp1, anti-β2gp1 antibodies and platelets: key players in the antiphospholipid syndrome

[7] Lipoprotein-lipase responses to heparin

[8] Traitement du purpura thrombopénique immunologique : étude rétrospective de 40 patients

[9] Changes in the Activity of Ovine Blood-derived Macrophages Stimulated with Antimicrobial Peptide Extract (AMP) or Platelet-rich Plasma (PRP).

[10] Redox Proteomics and Platelet Activation: Understanding the Redox Proteome to Improve Platelet Quality for Transfusion

[11] Proteomic analysis of Intercept-treated platelets.

[12] Space-Confined Growth of Individual Wide Bandgap Single Crystal CsPbCl Microplatelet for Near-Ultraviolet Photodetection.

[13] Thromboembolic, Bleeding, and Mortality Risks among Patients with Nonvalvular Atrial Fibrillation Treated with Dual Antiplatelet Therapy versus Oral Anticoagulants: A Population-Based Study.

[14] Economic evaluation of the use of non-Vitamin K oral anticoagulants in patients with atrial fibrillation on antiplatelet therapy: A modelling analysis using the healthcare system in the Netherlands

[15] Platelet-rich plasma plays an antibacterial, anti-inflammatory and cell proliferation-promoting role in an in vitro model for diabetic infected wounds

[16] The association between platelet indices and deep surgical site infection after open induction internal fixation for traumatic limb fractures

[17] Platelet reactivity in diabetic patients with invasive Klebsiella pneumoniae liver abscess syndrome

[18] Emerging role of dual antiplatelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma

[19] Platelet-rich plasma plays an antibacterial, anti-inflammatory and cell proliferation-promoting role in an in vitro model for diabetic infected wounds

[20] The association between platelet indices and deep surgical site infection after open induction internal fixation for traumatic limb fractures

[21] Platelet reactivity in diabetic patients with invasive Klebsiella pneumoniae liver abscess syndrome

[22] Preoperative Neutrophil-to-Lymphocyte Ratio Plus Platelet-to-Lymphocyte Ratio Predicts the Outcomes after Curative Resection for Hepatocellular Carcinoma

[23] Emerging role of dual antiplatelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma

[24] Porous Co<inf>3</inf>O<inf>4</inf> nanoplatelets as efficient catalyst precursor for hydrogen generation from the hydrolysis of alkaline sodium borohydride solution

[25] Combination therapy targeting platelet activation and virus replication protects mice against lethal influenza pneumonia.

[26] Ir-6: A Novel Iridium (III) Organometallic Derivative for Inhibition of Human Platelet Activation

[27] Association of glycemic status and interferon-γ production with leukocytes and platelet indices alterations in type2 diabetes

[28] Relationship of Platelet Reactivity and Inflammatory Markers to Recurrent Adverse Events in Patients with ST-Elevation Myocardial Infarction.

[29] Analysis of cytokine profile and growth factors in platelet-rich plasma obtained by open systems and commercial columns.

[30] Septic shock during platelet transfusion in a patient with acute myeloid leukaemia.

[31] Does the timing of aspirin administration influence its antiplatelet effect - review of literature on chronotherapy.

[32] Effects of Edoxaban on the Cellular and Protein Phase of Coagulation in Patients with Coronary Artery Disease on Dual Antiplatelet Therapy with Aspirin and Clopidogrel: Results of the EDOX-APT Study.

[33] The use of stromal vascular fraction (SVF), platelet-rich plasma (PRP) and stem cells in the treatment of osteoarthritis: an overview of clinical trials

[34] Mesenchymal Stem Cells and Platelet Gel Improve Bone Deposition within CAD-CAM Custom-Made Ceramic HA Scaffolds for Condyle Substitution

[35] Comparison of Effects of Pulsed Electromagnetic Field Stimulation on Platelet-Rich Plasma and Bone Marrow Stromal Stem Cell Using Rat Zygomatic Bone Defect Model.

[36] The contribution of platelet studies to the understanding of disease mechanisms in complex and monogenetic neurological disorders

[37] Experimental investigations of using MWCNTs and graphene nanoplatelets water-based nanofluids as coolants in PVT systems

[38] Heat transfer and pressure drop investigation of graphene nanoplatelet-water and titanium dioxide-water nanofluids in a horizontal tube

[39] Extracellular vesicles from CLEC2-activated platelets enhance dengue virus-induced lethality via CLEC5A/TLR2

[40] Platelet function in HIV plus dengue coinfection associates with reduced inflammation and milder dengue illness

[41] Comparative response of platelet fV and plasma fV to activated protein C and relevance to a model of acute traumatic coagulopathy.

[42] Design, Synthesis and Anti-Platelet Aggregation Activity Study of Ginkgolide-1,2,3-triazole Derivatives

[43] Platelet mitochondrial bioenergetic analysis in patients with nephropathies and non-communicable diseases: a new method.

[44] Inherited platelet disorders in women.

[45] Ultrasound-guided bilateral combined inguinal femoral and subgluteal sciatic nerve blocks for simultaneous bilateral below-knee amputations due to bilateral diabetic foot gangrene unresponsive to peripheral arterial angioplasty and bypass surgery in a coagulopathic patient on antiplatelet therapy with a history of percutaneous coronary intervention for ischemic heart disease: A case report

[46] Micro-Nano Carbon Structures with Platelet, Glassy and Tube-Like Morphologies.

[47] Mean platelet volume, neutrophil to lyphocyte ratio and platelet to lymphocyte ratio in psoriasis

[48] Collagen can selectively trigger a platelet secretory phenotype via glycoprotein VI.

[49] Reducing demand uncertainty in the platelet supply chain through artificial neural networks and ARIMA models.

[50] Antiplatelet therapy and anticoagulation in patients with hypertension.

[51] Can intra-articular injection of freeze-dried platelet-derived factor concentrate regenerate articular cartilage in the knee joint?

[52] Effects of the graphene nanoplatelets reinforced interphase on mechanical properties of carbon fibre reinforced polymer – A multiscale modelling study

[53] Microstructure and nanoindentation behavior of Cu composites reinforced with graphene nanoplatelets by electroless co-deposition technique.

[54] An Overview of Metal Matrix Nanocomposites Reinforced with Graphene Nanoplatelets; Mechanical, Electrical and Thermophysical Properties

[55] Antiplatelet therapy and coronary artery bypass grafting: Protocol for a systematic review and network meta-analysis.

[56] Relationship of Hypertensive Retinopathy with Mean Platelet Volume Among Hypertensive Patients.

[57] The Effect of Silymarin Flavonolignans and Their Sulfated Conjugates on Platelet Aggregation and Blood Vessels Ex Vivo.

[58] Platelet-Derived Growth Factor Receptor and Ionizing Radiation in High Grade Glioma Cell Lines.

[59] Knee Osteoarthritis Injection Choices: Platelet- Rich Plasma (PRP) versus Hyaluronic Acid (A one-year randomized clinical trial)

[60] Antiplatelet effect of differentially charged PEGylated lipid-polymer nanoparticles.

[61] A precision medicine approach to defining the impact of doxorubicin on the bioenergetic-metabolite interactome in human platelets.

[62] A precision medicine approach to defining the impact of doxorubicin on the bioenergetic-metabolite interactome in human platelets

[63] The Metabolites of the Dietary Flavonoid Quercetin Possess Potent Antithrombotic Activity, and Interact with Aspirin to Enhance Antiplatelet Effects.

[64] [Relation of Functional Activity of Platelets to Prognosis of Unfavorable Cardiovascular Events in Patients with Acute Coronary Syndrome. Results of a Registry Study].

[65] Platelet count and mean volume in acute stroke: a systematic review and meta-analysis.

[66] Impact of Extravasated Platelet Activation and Podoplanin-positive Cancer-associated Fibroblasts in Pancreatic Cancer Stroma.

[67] Effects of diltiazem on platelet activation and cytosolic calcium during percutaneous transluminal coronary angioplasty.

[68] Comparison of Connective Tissue Graft and Platelet Rich Fibrin as Matrices in A Novel Papillary Augmentation Access: A Randomized Controlled Clinical Trial.

[69] High-Efficiency Production of Large-Size Few-Layer Graphene Platelets via Pulsed Discharge of Graphite Strips.

[70] Functionalising Collagen-Based Scaffolds With Platelet-Rich Plasma for Enhanced Skin Wound Healing Potential

[71] Comparative evaluation of platelet rich plasma in socket healing and bone regeneration after surgical removal of impacted mandibular third molars

[72] Expression of CXCR4 in cord blood-derived CD133+ cells treated with platelet micro-particles.

[73] Perioperative antithrombotic (antiplatelet and anticoagulant) therapy in urological practice: a critical assessment and summary of the clinical practice guidelines.

[74] Can mean platelet volume be used as a biomarker for asthma?

[75] The diagnostic value of a globulin/platelet model for evaluating liver fibrosis in chronic hepatitis B patients

[76] Head-to-Head Comparison of Consensus-Recommended Platelet Function Tests to Assess P2Y Inhibition-Insights for Multi-Center Trials.

[77] Effectiveness and safety of autologous platelet-rich plasma therapy with total contact casting versus total contact casting alone in treatment of trophic ulcer in leprosy: An observer-blind, randomized controlled trial.

[78] Platelet Function and Therapeutic Applications in Dogs: Current Status and Future Prospects.

[79] Comparative impact of platelet rich plasma and transforming growth factor-β on chondrogenic differentiation of human adipose derived stem cells.

[80] Anterior Cruciate Ligament Reconstruction with Platelet-Rich Plasma: A Systematic Review of Randomized Control Trials.

[81] Impact of the different preparation methods to obtain autologous non‐activated platelet‐rich plasma (A‐PRP) and activated platelet‐rich plasma (AA‐PRP) in plastic surgery: Wound healing and hair regrowth evaluation

[82] Platelet-Rich Plasma (PRP) is a Potential Self-Sourced Cognition Booster in Elderly Mice

[83] The Number of Platelets in Patient's Blood Influences the Mechanical and Morphological Properties of PRP-Clot and Lysophosphatidic Acid Quantity in PRP

[84] An open invitation on: Pathogen safety standard of human platelet lysate for regenerative medicine; beneficial use of PRP in treatment of musculoskeletal pathologies and newer challenges on vitamin B12 deficiency and metabolism- mediated thrombotic microangiopathy

[85] Autologous platelet-rich plasma (CuteCell PRP) safely boosts in vitro human fibroblast expansion

[86] Allogeneic platelet-rich plasma (PRP) is superior to platelets or plasma alone in stimulating fibroblast proliferation and migration, angiogenesis, and chemotaxis as relevant processes for wound healing

[87] Use of Biomaterials Associated or not to the Platelet-Rich Plasma in Cranial Bone Defects. Microscopical Study in Dogs

[88] The effect of oxLDL on microvesicle release from platelets, measured by a sensitive flow cytometry method.

[89] BONE GRAFTING ENHANCED BY PLATELET-RICH PLASMA IN TREATMENT OF AVASCULAR NECROSIS OF FEMORAL HEAD

[90] The Lipid Composition of Platelets and the Impact of Storage: An Overview.

[91] Platelet count is associated with sustained virological response rates in treatments for chronic hepatitis C.

[92] Aspartate aminotransferase to platelet ratio index as a prospective predictor of hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection.

[93] Mean platelet volume may not be an independent prognostic factor in breast cancer patients with type 2 diabetes mellitus

[94] CD133 ⁺ bone marrow stem cells (BMSC) control platelet activation – Role of ectoNTPDase-1 (CD39)

[95] Targeting CD39 Toward Activated Platelets Reduces Systemic Inflammation and Improves Survival in Sepsis: A Preclinical Pilot Study

[96] Evaluation of New Bone Formation Using Autogenous Tooth Bone Graft Combined with Platelet-Rich Fibrin in Calvarial Defects.

[97] A Randomized Controlled Trial Comparing Platelet-Rich Plasma, Low-Level Laser Therapy, and Complex Decongestive Physiotherapy in Patients with Lower Limb Lymphedema.

[98] Leptospira interrogans Bat proteins impair host hemostasis by fibrinogen cleavage and platelet aggregation inhibition.

[99] Preactivated and disaggregated shape-changed platelets protect kidney against from ischemia-reperfusion injury in rat through attenuating inflammation reaction

[100] Platelet-to-lymphocyte ratio is associated with prognosis in patients with Corona Virus Disease-19.

[101] Decrease in 130 kDa- amyloid protein precursor protein (app) and APP protein ratio in schizophrenia platelets.